首页> Blood: The Journal of the American Society of Hematology> Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab)

Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab)

导出原文传递

翻译打印收藏纠错

作者： Tam,C.S. ^[1] ; O'Brien,S. ^[2] ; Plunkett,W. ^[3] ; Wierda,W. ; Ferrajoli,A. ; Wang,X. ; Do,K.-A. ; Cortes,J. ; Khouri,I. ; Kantarjian,H. ; Lerner,S. ; Keating,M.J.

作者单位： Leukemia Department, Unit 428, University of Texas MD Anderson Cancer Center, 1515 Holcombe ^[1] Biostatistics Department and, United States ^[2] Stem Cell Transplantation and Cellular Therapies, University of Texas MD Anderson Cancer ^[3]

发布时间 2015-02-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Blood

2014年124卷20期

3059-3064页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab)

Blood

相似文献

Blood

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab)

Blood

相似文献

Blood

相关期刊

检索历史清除